Pregnancy: No Reason Not to Treat Migraine

Evolving Perceptions and Care Challenges in Migraine: Michael Marmura, MD

The director of outpatient care at Jefferson Headache Center reflected on advances in migraine care and the ongoing outpatient challenges in treating this widespread yet under-recognized condition. [WATCH TIME: 3 minutes]

Pregnancy: No Reason Not to Treat Migraine

Sumatriptan and onabotulinumtoxinA are safe options during pregnancy.

Clinically Speaking: Questions and Answers About Migraine Treatments

Migraine attacks aren’t just head pain. They’re part of migraine disease, a neurologic disorder, and they involve a wide variety of symptoms that can include intense headache attacks, particularly occurring on one side of the head; sensitivity to light, sounds and smells; tingling or numbness in your arms and/or legs, mood changes and intense fatigue, among other symptoms.This chronic condition can be difficult to treat, but there are a lot of d…

Migraine Advocacy Gains Momentum at European Parliament

At a recent European Parliament event, the European Migraine and Headache Alliance (EMHA) called on EU policymakers to include migraine in the forthcoming Neurological Health Strategy. Despite affecting up to 15% of adults in Europe and being a leading cause of disability among young women, migraine remains underdiagnosed and undertreated. EMHA’s white paper, backed by 60 patient organizations and AbbVie, emphasizes the need for timely diagnosis…

EBC Endorses the EMHA White Paper on Strategic Advocacy Framework to Improve Migraine Care and Support

Migraine is a complex and often debilitating bio-neurological disorder affecting a significant portion of the global population. Despite being the second leading cause of years lived with disability globally, as reported in the 2019 Global Burden of Disease Study, migraine remains underrecognised and undertreated. This lack of attention results in delayed diagnoses, inadequate